Carnegie Medical

The investment objective of the fund is to achieve long-term capital growth through global investment in equities of companies operating in the pharmaceutical, biotechnology and medical technology sectors. The emphasis is on large-cap companies, however a considerable part of the portfolio consists of mid and small-cap companies. These are often more difficult to value and less analyzed than large cap companies.